RU2017134418A3 - - Google Patents

Download PDF

Info

Publication number
RU2017134418A3
RU2017134418A3 RU2017134418A RU2017134418A RU2017134418A3 RU 2017134418 A3 RU2017134418 A3 RU 2017134418A3 RU 2017134418 A RU2017134418 A RU 2017134418A RU 2017134418 A RU2017134418 A RU 2017134418A RU 2017134418 A3 RU2017134418 A3 RU 2017134418A3
Authority
RU
Russia
Application number
RU2017134418A
Other languages
Russian (ru)
Other versions
RU2017134418A (ru
RU2762685C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017134418A publication Critical patent/RU2017134418A/ru
Publication of RU2017134418A3 publication Critical patent/RU2017134418A3/ru
Application granted granted Critical
Publication of RU2762685C2 publication Critical patent/RU2762685C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2017134418A 2011-07-12 2012-07-12 Выявление аффинно-зрелых человеческих антител RU2762685C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161506749P 2011-07-12 2011-07-12
US61/506,749 2011-07-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014102617A Division RU2636045C2 (ru) 2011-07-12 2012-07-12 Выявление аффинно-зрелых человеческих антител

Publications (3)

Publication Number Publication Date
RU2017134418A RU2017134418A (ru) 2019-02-07
RU2017134418A3 true RU2017134418A3 (https=) 2021-06-10
RU2762685C2 RU2762685C2 (ru) 2021-12-22

Family

ID=47506915

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2017134418A RU2762685C2 (ru) 2011-07-12 2012-07-12 Выявление аффинно-зрелых человеческих антител
RU2014102617A RU2636045C2 (ru) 2011-07-12 2012-07-12 Выявление аффинно-зрелых человеческих антител

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2014102617A RU2636045C2 (ru) 2011-07-12 2012-07-12 Выявление аффинно-зрелых человеческих антител

Country Status (11)

Country Link
US (6) US9234030B2 (https=)
EP (2) EP2731965A4 (https=)
JP (1) JP6731702B2 (https=)
KR (1) KR102139388B1 (https=)
CN (2) CN107090459A (https=)
AU (2) AU2012281078B2 (https=)
CA (1) CA2841475C (https=)
IL (2) IL230358B (https=)
MX (2) MX361600B (https=)
RU (2) RU2762685C2 (https=)
WO (1) WO2013009967A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6731702B2 (ja) * 2011-07-12 2020-07-29 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 親和性成熟化ヒト抗体の同定
US10119134B2 (en) 2013-03-15 2018-11-06 Abvitro Llc Single cell bar-coding for antibody discovery
GB201316644D0 (en) * 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
WO2015182749A1 (ja) * 2014-05-30 2015-12-03 国立大学法人富山大学 TCR cDNAの増幅方法
KR101753553B1 (ko) 2014-06-03 2017-07-03 엑스바이오테크, 인크. 스타필로코커스 아우레우스 감염의 치료 및 예방을 위한 조성물 및 방법
ES2895750T3 (es) 2014-09-15 2022-02-22 Abvitro Llc Secuenciación de alto rendimiento de colecciones de nucleótidos
US10975146B2 (en) 2018-06-29 2021-04-13 Cedars-Sinai Medical Center Interleukin-1 inhibition for combination treatment of pancreatic cancer
US20200392578A1 (en) * 2019-06-14 2020-12-17 The Regents Of The University Of California Methods of sequencing antibody chains from hybridomas and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE284897T1 (de) * 2000-03-10 2005-01-15 Large Scale Biology Corp Selfantigen-impfstoffe zur behandlung von b-zell lymphomen und sonstigen krebsen
AU2002953381A0 (en) * 2002-12-18 2003-01-09 Diatech Pty Ltd In vivo affinity maturation scheme
BRPI0412217A (pt) * 2003-07-29 2006-08-22 Genentech Inc método de avaliação da eficácia de anticorpo, métodos de imunoterapia, método de detecção de anticorpos neutralizantes a anticorpo terapêutico e método de avaliação da eficácia de antagonista
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
PE20071101A1 (es) 2005-08-31 2007-12-21 Amgen Inc Polipeptidos y anticuerpos
JP5205597B2 (ja) * 2007-06-01 2013-06-05 静岡県 1細胞レベルでの抗体遺伝子の解析・同定方法
RU2011117213A (ru) * 2008-09-30 2012-11-10 Эббот Лэборетриз (Us) Улучшенные библиотеки антител
EP2398913B1 (en) 2009-02-20 2016-03-30 F. Hoffmann-La Roche AG Method for obtaining immunoglobulin encoding nucleic acid
JP6731702B2 (ja) * 2011-07-12 2020-07-29 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 親和性成熟化ヒト抗体の同定

Also Published As

Publication number Publication date
US9394536B2 (en) 2016-07-19
IL262977A (en) 2018-12-31
EP3034513A2 (en) 2016-06-22
KR20140044905A (ko) 2014-04-15
IL230358B (en) 2018-11-29
US9453217B2 (en) 2016-09-27
JP6731702B2 (ja) 2020-07-29
MX2014000431A (es) 2014-09-04
US20200071388A1 (en) 2020-03-05
KR102139388B1 (ko) 2020-07-30
EP2731965A2 (en) 2014-05-21
EP3034513A3 (en) 2016-08-10
US20130018173A1 (en) 2013-01-17
WO2013009967A2 (en) 2013-01-17
EP2731965A4 (en) 2015-06-03
JP2014521316A (ja) 2014-08-28
WO2013009967A3 (en) 2013-04-04
CN103687873B (zh) 2016-10-19
EP3034513B1 (en) 2020-09-02
AU2017210585B2 (en) 2019-07-25
AU2012281078B2 (en) 2017-05-04
CA2841475C (en) 2021-02-09
AU2012281078A1 (en) 2014-01-23
US9670483B2 (en) 2017-06-06
US9234030B2 (en) 2016-01-12
MX2018015450A (es) 2021-11-16
RU2017134418A (ru) 2019-02-07
RU2014102617A (ru) 2015-08-20
CN103687873A (zh) 2014-03-26
US20160060618A1 (en) 2016-03-03
AU2017210585A1 (en) 2017-08-24
CN107090459A (zh) 2017-08-25
US20160060619A1 (en) 2016-03-03
MX361600B (es) 2018-12-11
CA2841475A1 (en) 2013-01-17
US20170233457A1 (en) 2017-08-17
IL262977B (en) 2020-07-30
RU2636045C2 (ru) 2017-11-17
RU2762685C2 (ru) 2021-12-22
US20160362679A1 (en) 2016-12-15

Similar Documents

Publication Publication Date Title
BR112013031251A2 (https=)
BR112013027245A2 (https=)
BR112013026905A2 (https=)
BR112013027830A2 (https=)
BR112013026744A2 (https=)
AP3853A (https=)
BR112013027452A2 (https=)
BR112013028733A2 (https=)
BR112013027121A2 (https=)
AP2016009466A0 (https=)
BR112013026790A2 (https=)
BR112013024588A2 (https=)
BR112013031556A2 (https=)
BR112013032366A2 (https=)
BR112013032377A2 (https=)
BR112013032380A2 (https=)
BR112013027836A2 (https=)
BR112013026895A2 (https=)
BR112013027761A2 (https=)
BR112013025487A2 (https=)
BR112013032392A2 (https=)
BR112013030734A2 (https=)
BR112013017878A2 (https=)
BR112013027871A2 (https=)
RU2017134418A3 (https=)